Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALGRX 3268 for venipuncture pain in children
NCT00132405Phase 2Completed
- Sponsor
- AlgoRx Pharmaceuticals
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lidocaine in procedural pain (2 arms), sponsored by AlgoRx Pharmaceuticals. Primary endpoint: Subject's assessment of the pain of venipuncture. Started May 2004; status: completed.
02
Drugs
lidocaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT00132405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132405.